Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

002001.SZ Gross Margin

The Gross Margin of Zhejiang Nhu Co Ltd (002001.SZ) is 43.64%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

002001.SZ Gross Margin - Historical Value
Date Value
2025-12-31 43.64%
2024-12-31 41.55%
2023-12-31 31.45%
2022-12-31 35.91%
2021-12-31 44.18%
2020-12-31 54.04%
2019-12-31 46.88%
2018-12-31 53.09%
2017-12-31 50.12%
2016-12-31 44.83%
002001.SZ Gross Margin - Peers Comparison
Ticker Name Value
300558.SZ Betta Pharmaceuticals Co Ltd 81.38%
600521.SS Zhejiang Huahai Pharmaceutical Co Ltd 60.85%
603707.SS Nanjing King-friend Biochemical Pharmaceutical Co Ltd 46.17%
000739.SZ Apeloa Pharmaceutical Co Ltd 25.41%
002294.SZ Shenzhen Salubris Pharmaceuticals Co Ltd 71.63%
002603.SZ Shijiazhuang Yiling Pharmaceutical Co Ltd 46.47%
300357.SZ Zhejiang Wolwo Bio-Pharmaceutical Co Ltd 95.16%
600380.SS Joincare Pharmaceutical Group Industry Co Ltd 62.12%
603858.SS Shandong Buchang Pharmaceuticals Co Ltd 59.04%
000423.SZ Dong-E-E-Jiao Co Ltd 73.45%
000513.SZ Livzon Pharmaceutical Group Inc 65.58%
002653.SZ Haisco Pharmaceutical Group Co Ltd 71.14%
2096.HK Simcere Pharmaceutical Group Ltd 81.61%
000999.SZ China Resources Sanjiu Medical & Pharmaceutical Co Ltd 53.97%
603456.SS Zhejiang Jiuzhou Pharmaceutical Co Ltd 30.89%
002422.SZ Sichuan Kelun Pharmaceutical Co Ltd 47.24%
002821.SZ Asymchem Laboratories (Tianjin) Co Ltd 41.12%
600085.SS Beijing Tong Ren Tang Co Ltd 42.31%
002626.SZ Xiamen Kingdomway Group Co 38.33%
300363.SZ Porton Pharma Solutions Ltd 29.11%
600079.SS Humanwell Healthcare Group Co Ltd 48.11%
600566.SS Hubei Jumpcan Pharmaceutical Co Ltd 79.21%
867.HK China Medical System Holdings Ltd 71.50%
002399.SZ Shenzhen Hepalink Pharmaceutical Group Co Ltd 31.14%
002773.SZ Chengdu Kanghong Pharmaceutical Group Co Ltd 89.46%
600867.SS Tonghua Dongbao Pharmaceutical Co Ltd 72.75%
002019.SZ Yifan Pharmaceutical Co Ltd 46.79%
460.HK Sihuan Pharmaceutical Holdings Group Ltd 68.83%